# LumiThera to acquire Diopsys

LumiThera Inc. entered a definitive merger agreement to acquire Diopsys, Inc., a leader in visual electrophysiology medical devices, making Diopsys a wholly owned subsidiary.

- Type: Acquisition
- Announced: 2021-11-11
- Where: United States
- Status: announced
- Products: photobiomodulation treatment, visual electrophysiology devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [LumiThera](https://endata.com/companies/58937.md) (acquirer)
- [Diopsys](https://endata.com/companies/58938.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/lumithera-inc-announces-creation-of-a-light-based-theranostic-approach-to-treat-ocular-disease-with-acquisition-of-diopsys-inc-301421902.html), 2021-11-11: "The acquisition should provide a complementary diagnosis and monitoring platform to LumiThera's leading treatment platform using Photobiomodulation (PBM) for ocular disease and damage."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.